PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 16 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous and ethanolic extracts significantly inhibited arthritic development, paw edema, bone erosion, and inflammatory cell infiltration in animal models [PMID:30970284].
Selenium nanoparticles synthesized from D. indica leaf extract exhibited dose-dependent toxicity (IC50 of 43.21 μg/mL) and induced apoptosis in A549 cells [PMID:39558605].
D. indica is part of a polyherbal mixture evaluated for SGLT2 inhibitory effects in type 2 diabetic rats [PMID:36081821].
A purified chitinase from the bulbs acted as a growth inhibitor for Fusarium oxysporum and Rhizoctonia solani in vitro [PMID:16739943].
Evidence summary
PubMed sources
- 1.PMID: 31181697 (2019) — Drimia indica: A Plant Used in Traditional Medicine and Its Potential for Clinical Uses. · Medicina (Kaunas, Lithuania)
- 2.PMID: 25052711 (2015) — Karyological relationships in Indian species of Drimia based on fluorescent chromosome banding and nuclear DNA amount. · Protoplasma
- 3.PMID: 39410890 (2025) — Integrated Transcriptomics and Metabolomics Studies Reveal Steroid Biosynthesis Pathway and BCL2 Inhibitory Diazo-progesterone of Drimia indica for Conservation and Sustainable Utilization. · Current pharmaceutical biotechnology
- 4.PMID: 26155682 (2015) — Diversity of Drimia indica (Roxb.) Jessop and its relationship to Drimia nagarjunae using phenotypic traits and molecular markers. · Indian journal of experimental biology
- 5.PMID: 39558605